Profiling drugs for rheumatoid arthritis that inhibit synovial fibroblast activation

Profiling drugs for rheumatoid arthritis that inhibit synovial fibroblast activation

Activation of synovial fibroblasts (SFs) contributes to rheumatoid arthritis (RA) by damaging synovial membranes and generating inflammatory cytokines that recruit immune cells to the joint. In this paper we profile cytokine secretion by primary human SFs from healthy tissues and from donors with RA...

Full description

Bibliographic Details
Main Authors: Jenney, Anne P (Author), Swantek, Jennifer L (Author), Burke, John M (Author), Sorger, Peter K (Author), Jones II, Douglas S. (Contributor), Lauffenburger, Douglas A (Contributor)
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. Department of Biology (Contributor)
Format: Article
Language:English
Published: Springer Nature, 2018-09-11T13:46:23Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items